<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6839921\results\search\tropicalVirus\results.xml">
  <result pre="arginine substitutions at distinct residues within the E2 glycoproteins of" exact="CHIKV" post="and ONNV (E2 K200R) as well as RRV (E2"/>
  <result pre="unprecedented scale, leading to global outbreaks of diseases such as" exact="Zika" post="or chikungunya fever. The severity of these diseases and"/>
  <result pre="several decades, multiple arboviruses, including dengue (DENV), chikungunya (CHIKV), and" exact="Zika" post="(ZIKV) viruses, have re-emerged to cause widespread epidemics affecting"/>
  <result pre="can result in death (Bhatt et al., 2013). Since 2004," exact="CHIKV" post="has infected millions of people and expanded into Europe,"/>
  <result pre="stiffness, and tenosynovitis, can endure for months to years after" exact="CHIKV" post="infection (Borgherini et al., 2008; Couturier et al., 2012;"/>
  <result pre="Rodriguez-Morales et al., 2016; Schilte et al., 2013). As chronic" exact="CHIKV" post="disease is debilitating, large epidemics have severe economic impact"/>
  <result pre="al., 2015; Soumahoro et al., 2011; Vijayakumar et al., 2013)." exact="ZIKV" post="caused outbreaks on Yap Island (Duffy et al., 2009)"/>
  <result pre="being introduced to the Americas (Metsky et al., 2017). Here," exact="ZIKV" post="caused nearly one million confirmed and suspected cases and"/>
  <result pre="(K) to arginine (R) mutations in the E2 glycoproteins of" exact="CHIKV" post="and o’nyong ‘nyong virus (ONNV) (E2 K200R), as well"/>
  <result pre="rapid viral dissemination. Moreover, substitution of the lysine residues at" exact="CHIKV" post="E2 200 or RRV E2 251 with a variety"/>
  <result pre="fraction of the blood (Figure 1—figure supplement 1), demonstrating that" exact="CHIKV" post="particles had been removed from the circulation. These findings"/>
  <result pre="(CLL). At 42 hr post-treatment, mice were inoculated i.v. with" exact="CHIKV" post="(A), ONNV (B) or RRV (C), and viral genomes"/>
  <result pre="Raw data for Figure 1A-C. LINK Liver Kupffer cells clear" exact="CHIKV" post="from the circulation The spleen and liver contain phagocytic"/>
  <result pre="was evaluated in mice that underwent sham or splenectomy surgeries." exact="CHIKV" post="was efficiently cleared from the circulation of splenectomized mice"/>
  <result pre="not required for clearance of circulating CHIKV. Moreover, CLL-pretreatment blocked" exact="CHIKV" post="clearance in splenectomized mice (Figure 2B), suggesting that the"/>
  <result pre="remaining phagocytic cells in the liver are sufficient to clear" exact="CHIKV" post="from the circulation. Consistent with this, CHIKV RNA accumulated"/>
  <result pre="sufficient to clear CHIKV from the circulation. Consistent with this," exact="CHIKV" post="RNA accumulated in the liver of control PLL-treated mice,"/>
  <result pre="the high amounts of virus present in contaminating blood. Moreover," exact="CHIKV" post="RNA is readily detectable by in situ hybridization in"/>
  <result pre="particles from the circulation. Figure 2. Liver Kupffer cells clear" exact="CHIKV" post="from the circulation. (A) WT C57BL/6 mice that underwent"/>
  <result pre="underwent a sham or splenectomy surgery were inoculated i.v. with" exact="CHIKV" post="and viral genomes in the inoculum and serum at"/>
  <result pre="CLL. At 42 hr post-treatment, mice were inoculated i.v. with" exact="CHIKV" post="and viral genomes in the inoculum (input) and serum"/>
  <result pre="C57BL/6 mice were treated as in (B) and inoculated with" exact="CHIKV" post="at 42 hr post-treatment. Livers were collected at 45"/>
  <result pre="two experiments. Figure 2—figure supplement 1 shows representative images of" exact="CHIKV" post="RNA Scope in situ hybridization and F4/80 IHC for"/>
  <result pre="and Jenne, 2018; van Lookeren Campagne et al., 2007). However," exact="CHIKV" post="and RRV particles were efficiently cleared from the circulation"/>
  <result pre="with CLL, poly(I) pretreatment potently inhibited the clearance of circulating" exact="CHIKV" post="and RRV particles (Figure 3C). Similar results were observed"/>
  <result pre="1998). To investigate the relative contributions of SR-A1 and MARCO," exact="CHIKV" post="clearance was evaluated in SR-A1-/- and MARCO-/- mice. CHIKV"/>
  <result pre="MARCO, CHIKV clearance was evaluated in SR-A1-/- and MARCO-/- mice." exact="CHIKV" post="particles were efficiently cleared from the circulation of SR-A1-/-"/>
  <result pre="pre-treatment of SR-A1-/- mice with poly(I) (Figure 3E), indicating that" exact="CHIKV" post="clearance was still occurring through a SR-dependent mechanism. In"/>
  <result pre="clearance was still occurring through a SR-dependent mechanism. In contrast," exact="CHIKV" post="particles remained readily detectable in the serum of MARCO-/-"/>
  <result pre="3F). Moreover, whereas pretreatment with CLL blocked clearance of circulating" exact="CHIKV" post="particles in WT mice, this treatment had no effect"/>
  <result pre="mice, this treatment had no effect on the level of" exact="CHIKV" post="in the circulation of MARCO-/- mice (Figure 3G). Furthermore,"/>
  <result pre="CHIKV in the circulation of MARCO-/- mice (Figure 3G). Furthermore," exact="CHIKV" post="RNA was detectable by in situ hybridization in the"/>
  <result pre="these findings demonstrate that MARCO is essential for clearance of" exact="CHIKV" post="particles from the circulation. Figure 3. The scavenger receptor"/>
  <result pre="3. The scavenger receptor MARCO is required for clearance of" exact="CHIKV" post="and RRV. (A) WT or C3-/- C57BL/6 mice were"/>
  <result pre="3—source data 1. Raw data for Figure 3A-G, I. LINK" exact="CHIKV" post="E2 K200R evades phagocytic cell-mediated clearance We next investigated"/>
  <result pre="clearance of alphaviral particles from the circulation. In prior studies," exact="DENV" post="and West Nile virus (WNV) clearance from the circulation"/>
  <result pre="alphaviral particles from the circulation. In prior studies, DENV and" exact="West Nile" post="virus (WNV) clearance from the circulation of mice was"/>
  <result pre="N-linked glycans on viral envelope glycoproteins (Fuchs et al., 2010)." exact="CHIKV" post="E2 is predicted to be glycosylated at N345, N263"/>
  <result pre="or in combination, had no effect on the clearance of" exact="CHIKV" post="particles from the circulation (Figure 4—figure supplement 1), demonstrating"/>
  <result pre="the circulation (Figure 4—figure supplement 1), demonstrating that clearance of" exact="CHIKV" post="particles does not rely on glycosylation at these sites."/>
  <result pre="at these sites. Previously, we identified a mutation in the" exact="CHIKV" post="E2 glycoprotein (E2 K200R) in virus persistently circulating in"/>
  <result pre="in Rag1-/- mice (Hawman et al., 2017). This mutation enhanced" exact="CHIKV" post="dissemination in mice following subcutaneous inoculation and caused more"/>
  <result pre="role for phagocytic cells and MARCO in the clearance of" exact="CHIKV" post="particles from the circulation, we hypothesized that the E2"/>
  <result pre="unlike WT CHIKV, which is efficiently cleared from the circulation," exact="CHIKV" post="E2 K200R particles remained stably detectable in the serum"/>
  <result pre="were derived, as differential clearance of WT and E2 K200R" exact="CHIKV" post="particles was maintained when virions were derived from human"/>
  <result pre="not due to differential stability of WT and E2 K200R" exact="CHIKV" post="particles (Figure 4—figure supplement 2A). Moreover, the levels of"/>
  <result pre="(Figure 4—figure supplement 2A). Moreover, the levels of E2 K200R" exact="CHIKV" post="particles in control PLL-treated mice were indistinguishable from WT"/>
  <result pre="control PLL-treated mice were indistinguishable from WT and E2 K200R" exact="CHIKV" post="particles in the circulation of mice pre-treated with CLL"/>
  <result pre="circulation of mice pre-treated with CLL (Figure 4C), demonstrating that" exact="CHIKV" post="E2 K200R allows for evasion of phagocytic cell-mediated clearance."/>
  <result pre="and BALB/cJ mouse strains (Figure 4—figure supplement 2B). Figure 4." exact="CHIKV" post="E2 K200R evades phagocytic cell-mediated clearance. (A) WT C57BL/6"/>
  <result pre="cell-mediated clearance. (A) WT C57BL/6 mice were inoculated i.v. with" exact="CHIKV" post="or CHIKV E2 K200R, and viral genomes in the"/>
  <result pre="(A) WT C57BL/6 mice were inoculated i.v. with CHIKV or" exact="CHIKV" post="E2 K200R, and viral genomes in the inoculum and"/>
  <result pre="****p&amp;lt;0.0001. (B) WT C57BL/6 mice were inoculated with human fibroblast-derived" exact="CHIKV" post="or CHIKV E2 K200R, and viral genomes in the"/>
  <result pre="WT C57BL/6 mice were inoculated with human fibroblast-derived CHIKV or" exact="CHIKV" post="E2 K200R, and viral genomes in the inoculum and"/>
  <result pre="or clodronate liposomes 42 hr prior to i.v. inoculation with" exact="CHIKV" post="or CHIKV E2 K200R. Viral genomes in the inoculum"/>
  <result pre="liposomes 42 hr prior to i.v. inoculation with CHIKV or" exact="CHIKV" post="E2 K200R. Viral genomes in the inoculum and serum"/>
  <result pre="shows that mutation of E2 glycosylation sites does not influence" exact="CHIKV" post="clearance from the circulation. Figure 4—figure supplement 2 shows"/>
  <result pre="the E2 K200R mutation does not alter the thermostability of" exact="CHIKV" post="particles in serum (A), and that the E2 K200R"/>
  <result pre="in serum (A), and that the E2 K200R mutation allows" exact="CHIKV" post="particles to evade clearance from the circulation in multiple"/>
  <result pre="effects of the E2 K200R mutation were unique to the" exact="CHIKV" post="strain tested (AF15561; Asian genotype) or functioned within broader"/>
  <result pre="we introduced an E2 K200R mutation into the genome of" exact="CHIKV" post="strains representative of all phylogenetic lineages: Asian-American (strain 99659;"/>
  <result pre="SG650 strain of ONNV (Lanciotti et al., 1998). Similar to" exact="CHIKV" post="AF15561, all WT strains of CHIKV and ONNV were"/>
  <result pre="al., 1998). Similar to CHIKV AF15561, all WT strains of" exact="CHIKV" post="and ONNV were cleared from the circulation at 45"/>
  <result pre="mutation broadly facilitates evasion of phagocytic-cell mediated clearance in multiple" exact="CHIKV" post="strains, as well as the related ONNV. An E2"/>
  <result pre="or MARCO-/- C57BL/6 mice were inoculated as in (A) with" exact="CHIKV" post="or CHIKV E2 K200R. At 24 hpi, infectious virus"/>
  <result pre="C57BL/6 mice were inoculated as in (A) with CHIKV or" exact="CHIKV" post="E2 K200R. At 24 hpi, infectious virus in the"/>
  <result pre="inoculation of virus, we inoculated MARCO-/- mice subcutaneously with WT" exact="CHIKV" post="and evaluated viral burdens at 1 d post-inoculation. Similar"/>
  <result pre="1 d post-inoculation. Similar to infection of WT mice with" exact="CHIKV" post="E2 K200R, infection of MARCO-/- mice with WT CHIKV"/>
  <result pre="with CHIKV E2 K200R, infection of MARCO-/- mice with WT" exact="CHIKV" post="resulted in an elevated viremia and more rapid viral"/>
  <result pre="5B). Collectively, these findings indicate that MARCO-dependent clearance of circulating" exact="CHIKV" post="particles controls viremia and impedes viral dissemination. CHIKV E2"/>
  <result pre="of circulating CHIKV particles controls viremia and impedes viral dissemination." exact="CHIKV" post="E2 K200R does not impact vector competence or viral"/>
  <result pre="mosquitoes. Following blood-feeding inoculation of mosquitoes, similar levels of WT" exact="CHIKV" post="and E2 K200R were detected in the bodies, legs"/>
  <result pre="in vitro and in vivo competition experiments with a WT" exact="CHIKV" post="strain genetically marked with an ApaI restriction site (CHIKV-ApaI)."/>
  <result pre="with an ApaI restriction site (CHIKV-ApaI). Control 1:1 competitions of" exact="CHIKV" post="and CHIKV-ApaI in C6/36 cells (Figure 6B) and microinjected"/>
  <result pre="fitness. Similar results were observed following direct 1:1 competition of" exact="CHIKV" post="and CHIKV E2 K200R, (Figure 6B, C and D),"/>
  <result pre="results were observed following direct 1:1 competition of CHIKV and" exact="CHIKV" post="E2 K200R, (Figure 6B, C and D), suggesting that"/>
  <result pre="findings suggest that while the E2 K200R mutation dramatically influences" exact="CHIKV" post="dissemination in the vertebrate host, it is neutral in"/>
  <result pre="host, it is neutral in the mosquito vector. Figure 6." exact="CHIKV" post="E2 K200R has no impact on vector competence or"/>
  <result pre="fed a blood meal containing 1.1 × 106 PFU/mL of" exact="CHIKV" post="or CHIKV E2 K200R, and the head, legs, and"/>
  <result pre="blood meal containing 1.1 × 106 PFU/mL of CHIKV or" exact="CHIKV" post="E2 K200R, and the head, legs, and saliva were"/>
  <result pre="an MOI of 1 PFU/cell with a 1:1 mixture of" exact="CHIKV" post="marked with an ApaI restriction site (CHIKV-ApaI) and WT"/>
  <result pre="CHIKV marked with an ApaI restriction site (CHIKV-ApaI) and WT" exact="CHIKV" post="or CHIKV E2 K200R, and 1/10th of the supernatant"/>
  <result pre="with an ApaI restriction site (CHIKV-ApaI) and WT CHIKV or" exact="CHIKV" post="E2 K200R, and 1/10th of the supernatant was serially"/>
  <result pre="of 1:1 mixtures of CHIKV-ApaI and CHIKV, or CHIKV-ApaI and" exact="CHIKV" post="E2 K200R. Bodies (C) and saliva (D) were collected"/>
  <result pre="E2 K251 The critical lysine at position E2 200 of" exact="CHIKV" post="and ONNV is not conserved within RRV strains, which"/>
  <result pre="± SD. N = 6, two experiments. Kruskal-Wallis; **p&amp;lt;0.01. (C)" exact="CHIKV" post="trimeric spike (PDB 3J2W), with E2 K200 highlighted in"/>
  <result pre="residues at E2 200 or E2 251 are essential for" exact="CHIKV" post="and RRV clearance, respectively The impact of lysine to"/>
  <result pre="cells, we introduced a variety of amino acid substitutions at" exact="CHIKV" post="E2 200. The amino acid panel was designed to"/>
  <result pre="8A). Remarkably, all substitutions tested prevented efficient clearance of circulating" exact="CHIKV" post="particles following i.v. inoculation (Figure 8B). Moreover, a subset"/>
  <result pre="that mediates clearance in RRV (E2 K251) is conserved in" exact="CHIKV" post="(E2 K252). To investigate if this lysine residue also"/>
  <result pre="K252). To investigate if this lysine residue also contributes to" exact="CHIKV" post="clearance, we introduced an E2 K252R mutation. However, we"/>
  <result pre="we introduced an E2 K252R mutation. However, we found that" exact="CHIKV" post="E2 K252R remained susceptible to clearance by phagocytic cells"/>
  <result pre="lysine at this position in E2 is not required for" exact="CHIKV" post="clearance. Collectively, these findings demonstrate that specific lysine residues"/>
  <result pre="residues at E2 200 or E2 251 are essential for" exact="CHIKV" post="and RRV clearance, respectively. (A) Properties of the amino"/>
  <result pre="WT C57BL/6 mice were inoculated i.v. with a panel of" exact="CHIKV" post="mutants with different amino acid substitutions at position E2"/>
  <result pre="K; ****p&amp;lt;0.0001. (D) WT C57BL/6 mice were inoculated i.v. with" exact="CHIKV" post="or CHIKV E2 K252R, and viral genomes in inoculum"/>
  <result pre="(D) WT C57BL/6 mice were inoculated i.v. with CHIKV or" exact="CHIKV" post="E2 K252R, and viral genomes in inoculum and in"/>
  <result pre="the spleen is not necessary for the clearance of circulating" exact="CHIKV" post="particles, it remains possible that MZM contribute to the"/>
  <result pre="in vivo. Beyond GAGs, previous work demonstrated that opsonization of" exact="DENV" post="particles by mannose binding lectin (MBL), which can neutralize"/>
  <result pre="2010). However, we found that the innate clearance of circulating" exact="CHIKV" post="and RRV was maintained in mice lacking C3 and"/>
  <result pre="et al., 2013). We found that the clearance of circulating" exact="CHIKV" post="and RRV particles was inhibited by pre-treatment of mice"/>
  <result pre="critical roles for MARCO in the efficient clearance of circulating" exact="CHIKV" post="particles and for limiting viral dissemination and the magnitude"/>
  <result pre="of viremia, suggesting that MARCO may limit disease severity following" exact="CHIKV" post="infection. Beyond identification of the cell type and specific"/>
  <result pre="clearance of viral particles by phagocytic cells. N-linked glycosylation of" exact="DENV" post="and WNV glycoproteins was previously found to influence clearance"/>
  <result pre="viral particles by phagocytic cells. N-linked glycosylation of DENV and" exact="WNV" post="glycoproteins was previously found to influence clearance of these"/>
  <result pre="2010). However, we found that mutation of the predicted surface-exposed" exact="CHIKV" post="E2 glycosylation sites had no impact on the clearance"/>
  <result pre="E2 glycosylation sites had no impact on the clearance of" exact="CHIKV" post="particles from the circulation, suggesting that clearance occurs independent"/>
  <result pre="features that mediated clearance of circulating alphavirus particles, we identified" exact="CHIKV" post="and RRV strains that evade phagocytic cell-mediated clearance. CHIKV"/>
  <result pre="identified CHIKV and RRV strains that evade phagocytic cell-mediated clearance." exact="CHIKV" post="E2 K200R was isolated from the serum of a"/>
  <result pre="of a Rag1-/- mouse chronically infected with an Asian genotype" exact="CHIKV" post="strain (Hawman et al., 2017), suggesting that this mutation"/>
  <result pre="from the circulation. Introduction of an E2 K200R mutation into" exact="CHIKV" post="strains representative of the Asian-American, ECSA, and West African"/>
  <result pre="CHIKV strains representative of the Asian-American, ECSA, and West African" exact="CHIKV" post="clades also facilitated escape of viral particles from phagocytic"/>
  <result pre="To more thoroughly evaluate biochemical features of the residue at" exact="CHIKV" post="E2 200 or RRV E2 251 that promote particle"/>
  <result pre="clearance or particle escape from clearance, we generated panels of" exact="CHIKV" post="and RRV strains encoding amino acids at positions E2"/>
  <result pre="with the exception of lysine, all amino acid substitutions at" exact="CHIKV" post="E2 200 or RRV E2 251 allowed for evasion"/>
  <result pre="the circulation. These findings suggest that a lysine residue at" exact="CHIKV" post="E2 200 or RRV E2 251 is essential for"/>
  <result pre="variety of distinct genetic backgrounds to facilitate escape of circulating" exact="CHIKV" post="and ONNV particles from MARCO-dependent clearance; (2) a lysine"/>
  <result pre="mutating this lysine has no impact on clearance of circulating" exact="CHIKV" post="particles; (4) lysine is frequently post-translationally modified, and can"/>
  <result pre="amino acid at E2 200 or 251, lysine residues at" exact="CHIKV" post="E2 200, ONNV E2 200, and RRV E2 251"/>
  <result pre="the ViPR database (Pickett et al., 2012) revealed that 1,333/1,335" exact="CHIKV" post="sequences encode a lysine at position E2 200 (2/1,335"/>
  <result pre="fitness advantage in the mosquito vector. However, we found that" exact="CHIKV" post="E2 K200R replication and dissemination was indistinguishable from that"/>
  <result pre="K200R replication and dissemination was indistinguishable from that of WT" exact="CHIKV" post="in Ae. aegypti mosquitoes, and no selective disadvantage of"/>
  <result pre="direct competition experiments, suggesting that the conservation of lysine at" exact="CHIKV" post="E2 200 is not due to constraints in the"/>
  <result pre="cells has important implications for the course of infection. The" exact="CHIKV" post="E2 K200R strain that escapes MARCO-dependent clearance generates a"/>
  <result pre="et al., 2017). Analogously, infection of MARCO-/- mice with WT" exact="CHIKV" post="also resulted in enhanced viremia and more rapid viral"/>
  <result pre="in a higher magnitude and duration of viremia following subcutaneous" exact="CHIKV" post="infection of mice (Gardner et al., 2010). Similarly, clodronate"/>
  <result pre="al., 2010). Similarly, clodronate liposome depletion of phagocytic cells enhanced" exact="WNV" post="viremia and disease severity in mice (Bryan et al.,"/>
  <result pre="also greatly influences transmission cycles. While some arboviruses, such as" exact="WNV" post="and Japanese Encephalitis virus, are unable to generate a"/>
  <result pre="the transmission cycle (Weaver, 2018), others like CHIKV, DENV, and" exact="Zika" post="virus are readily amplified through human-mosquito-human cycles (Weaver, 2018)."/>
  <result pre="were incubated at 30°C. Cells tested negative for mycoplasma. Viruses" exact="CHIKV" post="strains used include Asian strain AF15561 (Ashbrook et al.,"/>
  <result pre="2011), and WA strain 37997 (Vanlandingham et al., 2005b). All" exact="CHIKV" post="stocks were derived from infectious cDNA clones by electroporating"/>
  <result pre="fibroblasts. Unless otherwise noted, AF15561 was used as the representative" exact="CHIKV" post="strain. RRV strains used include SN11 (Liu et al.,"/>
  <result pre="on BHK-21 cells or by RT-qPCR. The cDNA clone of" exact="CHIKV" post="99659 was a gift from Mark Heise (University of"/>
  <result pre="Mark Heise (University of North Carolina), the cDNA clones of" exact="CHIKV" post="37997 and ONNV SG650 were gifts from Stephen Higgs"/>
  <result pre="in TRIzol using the PureLink RNA mini kit (Life Technologies)." exact="CHIKV" post="cDNA was generated using random primers (Invitrogen) with SuperScript"/>
  <result pre="random primers (Invitrogen) with SuperScript IV reverse transcriptase (Life Technologies)." exact="CHIKV" post="genome copies were quantified by RT-qPCR using a CHIKV"/>
  <result pre="Technologies). CHIKV genome copies were quantified by RT-qPCR using a" exact="CHIKV" post="specific forward primer (5′-TTTGCGTGCCACTCTGG-3′) and reverse primer (5′-CGGGTCACCACAAAGTACAA-3′) with"/>
  <result pre="prior to i.v. inoculation with 2.5 × 109 genomes of" exact="CHIKV" post="AF15561 diluted in 100 μl of diluent. At 45"/>
  <result pre="cycle. Mosquitoes were provided an infectious blood meal containing either" exact="CHIKV" post="AF15561 WT or CHIKV AF15561 E2 K200R. Defibrinated calf"/>
  <result pre="an infectious blood meal containing either CHIKV AF15561 WT or" exact="CHIKV" post="AF15561 E2 K200R. Defibrinated calf blood was mixed 1:1"/>
  <result pre="viral competition assays, we generated a genetically marked clone of" exact="CHIKV" post="AF15561 using sight- directed mutagenesis (Forward Primer: 5′-ctaaactaaaggggcccaaagcagcagcgctgt-3′; Reverse"/>
  <result pre="an MOI of 1 PFU/cell with a 1:1 ratio of" exact="CHIKV" post="AF15561-ApaI and CHIKV AF15561 or CHIKV AF15561-ApaI and CHIKV"/>
  <result pre="1 PFU/cell with a 1:1 ratio of CHIKV AF15561-ApaI and" exact="CHIKV" post="AF15561 or CHIKV AF15561-ApaI and CHIKV AF15561 E2 K200R."/>
  <result pre="a 1:1 ratio of CHIKV AF15561-ApaI and CHIKV AF15561 or" exact="CHIKV" post="AF15561-ApaI and CHIKV AF15561 E2 K200R. Following a 1"/>
  <result pre="of CHIKV AF15561-ApaI and CHIKV AF15561 or CHIKV AF15561-ApaI and" exact="CHIKV" post="AF15561 E2 K200R. Following a 1 hr adsorption, virus"/>
  <result pre="the supernatant, and cDNA was generated as described above for" exact="CHIKV" post="quantification. For in vivo competition experiments, Aedes aegypti mosquitoes"/>
  <result pre="microinjected intrathoracically with 138 PFU of a 1:1 mixture of" exact="CHIKV" post="AF15561-ApaI and CHIKV AF15561 or CHIKV AF15561-ApaI and CHIKV"/>
  <result pre="138 PFU of a 1:1 mixture of CHIKV AF15561-ApaI and" exact="CHIKV" post="AF15561 or CHIKV AF15561-ApaI and CHIKV AF15561 E2 K200R."/>
  <result pre="a 1:1 mixture of CHIKV AF15561-ApaI and CHIKV AF15561 or" exact="CHIKV" post="AF15561-ApaI and CHIKV AF15561 E2 K200R. At seven dpi,"/>
  <result pre="of CHIKV AF15561-ApaI and CHIKV AF15561 or CHIKV AF15561-ApaI and" exact="CHIKV" post="AF15561 E2 K200R. At seven dpi, mosquito bodies and"/>
  <result pre="the manufacturer’s instructions. cDNA was generated as described above for" exact="CHIKV" post="quantification. Relative amounts of each virus in samples were"/>
  <result pre="using control PCR products amplified from cDNA plasmid clones of" exact="CHIKV" post="AF15561 WT or CHIKV AF15561-ApaI. Digested products were run"/>
  <result pre="amplified from cDNA plasmid clones of CHIKV AF15561 WT or" exact="CHIKV" post="AF15561-ApaI. Digested products were run on a 1% TAE"/>
  <result pre="inhaled particlesThe Journal of Experimental Medicine20026727210.1084/jem.2004073115263032 AshbrookAWBurrackKSSilvaLAMontgomerySAHeiseMTMorrisonTEDermodyTS2014Residue 82 of the" exact="Chikungunya" post="virus E2 attachment protein modulates viral dissemination and arthritis"/>
  <result pre="function during Blood-Borne infectionsFrontiers in Immunology660660910.3389/fimmu.2015.0048026648935 BorgheriniGPoubeauPJossaumeAGouixACotteLMichaultAArvin-BerodCPaganinF2008Persistent arthralgia associated with" exact="Chikungunya" post="virus: a study of 88 adult patients on reunion"/>
  <result pre="bottleneck as major evolutionary forcesPLOS Pathogens9e100359110.1371/journal.ppat.100359124009512 ChowAHerZOngEKChenJMDimatatacFKwekDJBarkhamTYangHRéniaLLeoYSNgLF2011Persistent arthralgia induced by" exact="Chikungunya" post="virus infection is associated with interleukin-6 and granulocyte macrophage"/>
  <result pre="for severe diseasePLOS Pathogens4e2910.1371/journal.ppat.004002918282093 CouturierEGuilleminFMuraMLeonLVirionJ-MLetortM-JDe ValkHSimonFVaillantV2012Impaired quality of life after" exact="Chikungunya" post="virus infection: a 2-year follow-up studyRheumatology511315132210.1093/rheumatology/kes01522427407 DaughertyMDMalikHS2012Rules of engagement:"/>
  <result pre="viruses promotes neurovirulencePNAS108160261603110.1073/pnas.111061710821896745 GérardinPFianuAMalvyDMussardCBoussaïdKRollotOMichaultAGaüzereBABréartGFavierF2011Perceived morbidity and community burden after a" exact="Chikungunya" post="outbreak: the TELECHIK survey, a population-based cohort studyBMC Medicine9510.1186/1741-7015-9-521235760"/>
  <result pre="in the E2 glycoprotein and the 3′ Untranslated Region Enhance" exact="Chikungunya" post="Virus Virulence in MiceJournal of Virology913210.1128/JVI.00816-17 HeilMLAlbeeAStraussJHKuhnRJ2001An amino acid"/>
  <result pre="the liverNature Immunology14996100610.1038/ni.269124048121 JonesJELongKMWhitmoreACSandersWThurlowLRBrownJAMorrisonCRVincentHPeckKMBrowningCMoormanNLimJKHeiseMT2017Disruption of the opal stop Codon attenuates" exact="Chikungunya" post="Virus-Induced arthritis and pathologymBio811610.1128/mBio.01456-17 JupilleHJOkoLStoermerKAHeiseMTMahalingamSGunnBMMorrisonTE2011Mutations in nsP1 and PE2"/>
  <result pre="virus E1 and E2 glycoproteins in insect cellsVirology Journal835310.1186/1743-422X-8-35321762510 MoroMLGagliottiCSilviGAngeliniRSambriVRezzaGMassimilianiEMattiviAGrilliEFinarelliACSpataroNPierroAMSeylerTMaciniPcollab:" exact="Chikungunya" post="Study Group2010Chikungunya virus in North-Eastern Italy: a seroprevalence surveyThe"/>
  <result pre="mouse model of chikungunya Virus–Induced Musculoskeletal Inflammatory DiseaseAJPA178324010.1016/j.ajpath.2010.11.018 MorrisonTE2014Reemergence of" exact="Chikungunya" post="virusJournal of Virology88116441164710.1128/JVI.01432-1425078691 MukhopadhyaySGordonS2004The role of scavenger receptors in"/>
  <result pre="choriomeningitis virus infectionEuropean Journal of Immunology272626263310.1002/eji.18302710239368619 SilvaLAKhomandiakSAshbrookAWWellerRHeiseMTMorrisonTEDermodyTS2014A single-amino-acid polymorphism in" exact="Chikungunya" post="virus E2 glycoprotein influences glycosaminoglycan utilizationJournal of Virology882385239710.1128/JVI.03116-1324371059 SmitJMWaartsBLKimataKKlimstraWBBittmanRWilschutJ2002Adaptation"/>
  <result pre="viruses with liposomes containing lipid-conjugated heparinJournal of Virology76101281013710.1128/JVI.76.20.10128-10137.200212239287 SoumahoroMKBoellePYGaüzereBAAtsouKPelatCLambertBLa RucheGGastellu-EtchegorryMRenaultPSarazinMYazdanpanahYFlahaultAMalvyDHanslikT2011The" exact="Chikungunya" post="epidemic on la réunion island in 2005-2006: a cost-of-illness"/>
  <result pre="and applicationsJournal of Immunological Methods174839310.1016/0022-1759(94)90012-48083541 VanlandinghamDLHongCKlinglerKTsetsarkinKMcElroyKLPowersAMLehaneMJHiggsS2005aDifferential infectivities of o'nyong-nyong and" exact="Chikungunya" post="virus isolates in anopheles gambiae and aedes aegypti mosquitoesThe"/>
  <result pre="aedes aegypti in MexicoPLOS Neglected Tropical Diseases9e000426310.1371/journal.pntd.000426326658798 VijayakumarKGeorgeBAnishTSRajasiRSTeenaMJSujinaCM2013Economic impact of" exact="Chikungunya" post="epidemic: out-of-pocket health expenditures during the 2007 outbreak in"/>
  <result pre="of Tropical Medicine and Public Health44546123682438 VolkSMChenRTsetsarkinKAAdamsAPGarciaTISallAANasarFSchuhAJHolmesECHiggsSMaharajPDBraultACWeaverSC2010Genome-scale phylogenetic analyses of" exact="Chikungunya" post="virus reveal independent emergences of recent epidemics and various"/>
  <result pre="and clinical presentation in nicaraguan patients infected with zika virus," exact="Chikungunya" post="virus, and dengue virusClinical Infectious Diseases631584159010.1093/cid/ciw58927578819 WeaverSC2018Prediction and prevention"/>
 </snippets>
</snippetsTree>
